Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10916821 | Pathology - Research and Practice | 2016 | 21 Pages |
Abstract
The c-MET IHC could be useful for screening of c-MET genetic alteration in NSCLC patients. Detailed criteria for c-MET IHC evaluation are necessary to determine how to best apply this approach in daily practice.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jung-Soo Pyo, Guhyun Kang, Won Jin Cho, Sang Bong Choi,